Udo Hoffmann MD, MPH

Hoffman-Udo-175px

Udo Hoffmann MD, MPH

Udo Hoffmann is Professor of Radiology at Harvard Medical School and Chief of the Division of Cardiovascular Imaging at the Department of Radiology at MGH. He is also the Director of the Cardiac MR PET CT Program, and the Director of the MGH Imaging Trial Center. Dr. Hoffmann earned his medical degree and doctorate from the University of Leipzig, Germany and his Master of Public Health from the Harvard School of Public Health. He then completed his residency at the Vienna General Hospital.

Dr. Hoffmann is a leader cardiovascular imaging and is the Principal Investigator of major NIH-supported clinical trials such as ROMICAT I, ROMICAT II, PROMISE (Diagnostic Testing Core) and the CT Imaging of the Framingham Heart Study Cohort. At MGH, he leads a multidisciplinary team with expertise in cardiovascular imaging, epidemiology, cost effectiveness analysis, and blood biomarkers. His research has resulted in numerous peer reviewed manuscripts, reviews and book chapters, among them major work on the characterization of high risk coronary atherosclerotic plaque. Dr. Hoffman's national and international responsibilities further include: Co-Chair of the Imaging Oversight Committee of the Framingham Heart Study, Associate Editor for Circulation Cardiovascular Imaging, member of national initiatives, guideline committees, and task forces for the Radiological Society of North America, American College of Radiology, Society for Cardiac Angiography and Interventions, American Heart Association, and American College of Cardiology, as well as a member of NIH review committees.

Dr. Hoffmann is the Co-Principal Investigator of the Data and Statistical Coordinating Center for the REPRIEVE trial, Co-Chair of the REPRIEVE protocol, and Co-Chair of the Data Management Committee.